Haptoglobin Phenotype and Smoking: Effects on Iron Levels in Parkinson’s Disease

The purpose of this project is to study the alterations in iron metabolism present in patients with Parkinson’s disease as compared to healthy subjects, and the effect of lifestyle habits such as smoking and diet, or genetic traits such as haptoglobin phenotype, on iron levels. The study is finished with recruitment.

 
Status: 
Completed
Study area: 
Neurology
Principal investigator: 
Paola Costa-Mallen, PhD
Co-investigator(s): 
Yoshimi Anzai, MD, MPH; Harvey Checkoway, PhD; Shu-Ching Hu, MD
Project period: 
02/01/2013- 01/31/2015
Completed date (for sorting): 
Saturday, January 31, 2015
Funded by: 
NIH/National Institute of Neurological Disorders and Stroke
Published in: 
Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk
Response to the letter “Haptoglobin phenotype and Parkinson disease risk
Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease
Research

Campus life

Connect with us on social media.

Stay up to date

Sign up for the latest on news, events, and registrations.
SIGN UP